Navigation Links
Vion Pharmaceuticals Holds Special Meeting of Stockholders

Stockholders Approve Board Authority to Implement Reverse Stock Split and

Reduce the Number of Total Shares and Authorized Shares

NEW HAVEN, Conn., Feb. 13 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION) announced that a Special Meeting of Stockholders was held at the Omni Hotel in New Haven, Connecticut today at 10:00 Eastern Time.

At the meeting, shareholders voted to approve amendments to the Company's Restated Certificate of Incorporation to:

-- effect a reverse stock split of the Company's outstanding common stock

of not less than 1-for-5 and not more than 1-for-10, with the exact

ratio to be set within that range by the Board of Directors without

further approval by stockholders; and

-- decrease the total number of shares and the number of shares of common

stock that the Company is authorized to issue.

Alan Kessman, Chief Executive Officer, said, "We are pleased that our shareholders have authorized our Board of Directors to implement a reverse stock split. We will now determine the appropriate split ratio to establish a price for our common stock allowing us to regain compliance with Nasdaq's listing requirements."

Vion Pharmaceuticals, Inc. is committed to extending the lives and improving the quality of life of cancer patients worldwide by developing and commercializing innovative cancer therapeutics. Vion has two agents in clinical trials. Cloretazine(R) (VNP40101M), a unique alkylating agent, is being evaluated in a pivotal Phase II trial as a single agent in elderly patients with de novo poor-risk acute myelogenous leukemia. Clinical trials of Cloretazine(R) (VNP40101M) as a single agent in small cell lung cancer, w

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... Chicago during an eight-day multi-state, multi-agency federal outreach ... , SWIFT V Tour brings together program ... seminar participants on their agency's Small Business Innovation ... programs and to discuss research topics. Entrepreneurs, scientists, ...
... from her series of entrepreneurial profiles, this week Teresa reviews ... which was published by O'Reilly Press in 2004. , ... a good thing. , ,The first essay in Hackers ... his junior high school cafeteria, mapping out lunch tables according ...
... Tuesday that it plans to implement extranet software from ... concerning human subjects. Expected to launch by first quarter of ... fully enhance the institution's Institutional Review Board. , ,This choice ... the Medical College of Wisconsin has nearly 800 ...
Cached Biology Technology:Federal grant seminar coming to Chicago as part of SWIFT V Tour 2Hackers & Painters: Big Ideas from the Computer Age 2Hackers & Painters: Big Ideas from the Computer Age 3Hackers & Painters: Big Ideas from the Computer Age 4Hackers & Painters: Big Ideas from the Computer Age 5Medical College of Wisconsin to automate its processes for human subject testing 2
(Date:4/16/2014)... improves during childhood, associated with structural changes in ... parietal cortices. New research from UC Davis is ... crucial time. Eventually, that could give insights into ... and during adolescence and affect memory, such as ... middle of the brain, the hippocampus plays a ...
(Date:4/16/2014)... of Dr. Martin Prechtl, Leo Heim and their colleagues ... discovered a new method of generating hydrogen using water ... of particular interest when it comes to fuel cell ... mild hydrogen production using water and formaldehyde", have recently ... , Among other applications, the new approach can be ...
(Date:4/15/2014)... Tucked away in Hartford, Connecticut, a Puerto Rican community ... cuisine that is so authentic it has caught the ... and Gregory J. Anderson (University of Connecticut) took a ... Rican markets of Hartford and uncovered evidence that gives ... been using for years: home is in the kitchen. ...
Breaking Biology News(10 mins):How kids' brain structures grow as memory develops 2The human food connection: A new study reveals more about our relationship to food 2The human food connection: A new study reveals more about our relationship to food 3
... 28, 2008 Presenting new research about national, home ... by a University of Houston professor and his colleagues ... when it comes to surveillance. Two ... the fifth annual Institute of Electrical and Electronics Engineers ...
... WCS report reveals surprisingly large populations of two ... Cambodia. The report counted 42,000 black-shanked douc langurs ... Seima Biodiversity Conservation Area, an estimate that represents ... the world. WCS scientists conducted the surveys with ...
... Following last summer,s record minimum ice cover in the Arctic, ... of polar sea-ice may again shrink to a level very ... mid-August depict that a new record of low sea-ice coverage ... above is a series of mosaics of the Arctic Ocean ...
Cached Biology News:National security remedies among topics at surveillance confab 2National security remedies among topics at surveillance confab 3Unexpected large monkey population discovered 2Arctic ice on the verge of another all-time low 2Arctic ice on the verge of another all-time low 3
HiTrap NHS-activated HP, 1 x 5 ml. Category: Chromatography Systems & Accessories, Systems....
Mouse Axl MAb (Clone 175128)...
Mouse GDF-8 Propeptide Affinity Purified Polyclonal Ab...
... S.J. Allen (1995) This book ... authorities on current issues relating to the ... major advances have been made recently which ... Topics include molecular neuropathology through clinical and ...
Biology Products: